Abstract:OBJECTIVE:To study the function and prognostic value of the recently identified tumor suppressor gene LKB1 in human breast cancer.METHODS:Estrogen receptor-positive human breast cancer cells of MCF-7 line and estrogen receptor-negative human breast cancer cells of the lines MDA-MB-435 and MDA-MB-231 were cultured and tested for the LKB1 expression. Plasmid pcDNA4 TOPO HisMAX/LKB1 expressing LKB1 was constructed and transfected into the MDA-MB-435 cells. PCR and Western blotting were used to detect the expressions of LKB1 mRNA and protein. Flow cytometry was used to determine the cell cycle. PCR and Western blotting were used to detect the expressions of LKB1 mRNA and protein in 121 human breast cancer samples. The association with relapse free survival (RFS) and overall survival (OS) was assessed by univariate analysis (log-rank test and Kaplan-Meier method).RESULTS:Human breast cells of MCF-7 line expressed LKB1 and the cells of MDA-MB-435 and MDA-MB-231 lines did not. Flow cytometry showed that 40.9% of the MDA-MB-435 transfected with pcDNA4 TOPO HisMAX/LKB1 was at the G(1) stage, a proportion significantly higher than that of the control (18.3%). The expressions of cyclin D1 and cyclin E were significantly down-regulated and the expression of p21(WAF1/CIP1) was significantly up-regualed. LKB1 was lowly expressed in 43 out of the 121 cases of breast cancer (35.4%) and highly expressed in 78 cases (64.6%). Low expression of LKB1 was correlated with pathological grade (P = 0.013), cancer size (P = 0.001), status of estrogen receptor (P = 0.048), and status of lymph nodes metastasis (P = 0.003). Univariate analysis showed that low expression of LKB1 was significantly correlated with shorter RFS (P = 0.048) and low OS (P = 0.003).CONCLUSION:Reintroducing LKB1 into breast cell of the lines lacking LKB1 expression restores LKB1 activity and induces growth suppression by G(1) cell cycle block. The LKB1 mediated G(1) cell cycle arrest is caused by up-regulation of the expression of p21(WAF1/CIP1) in MDA-MB-435 breast cancer cells.

LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool.

Lkb1 is indispensable for skeletal muscle development, regeneration, and satellite cell homeostasis.

Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure

The Tumor Suppressor Gene Lkb1 Is Associated With Prognosis In Human Breast Carcinoma

Polo-like kinase 1 is essential for early embryonic development and tumor suppression.

Enhanced Expression of LKB1 in Breast Cancer Cells Attenuates Angiogenesis, Invasion, and Metastatic Potential

Liver kinase B1 regulates the centrosome via PLK1

[Function and Prognostic Value of Tumor Suppressor Gene LKB1 in Human Breast Carcinoma].

P27(Kip1) (Cyclin-Dependent Kinase Inhibitor 1b) Controls Ovarian Development By Suppressing Follicle Endowment And Activation And Promoting Follicle Atresia In Mice

KIT in oocytes: a key factor for oocyte survival and reproductive lifespan

Inhibition of Mtor Signaling Pathway Delays Follicle Formation in Mice

MAPK3/1 participates in the activation of primordial follicles through mTORC1‐KITL signaling

LKB1 inactivation leads to centromere defects and genome instability via p53-dependent upregulation of survivin.

The ubiquitin ligase KBTBD8 regulates PKM1 levels via Erk1/2 and Aurora A to ensure oocyte quality.

LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.

Lkb1 Inhibits Breast Cancer Partially Through Repressing The Hedgehog Signaling Pathway

Regulation of mouse primordial follicle formation by signaling through the PI3K pathway

Oocyte-Specific Deletion of Pten in Mice Reveals a Stage-Specific Function of PTEN/PI3K Signaling in Oocytes in Controlling Follicular Activation

LKB1 and Cancer: the Dual Role of Metabolic Regulation.

LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors

AMPK-like proteins and their function in female reproduction and gynecologic cancer